The study of the embryotoxic effect of the drug "Endoseptam"

Author:

Eroshin A. I.1ORCID,Tremasova A. M.1ORCID,Biryulya V. V.1ORCID,Ganiev I. M.1ORCID,Khamidullin R. R.1ORCID

Affiliation:

1. Federal Center for Toxicological, Radiation and Biological Safety

Abstract

Most diseases affecting cows in the early stages of lactation are of an inflammatory nature and are associated with a decrease in reproductive function. Unfavorable environmental factors cause metabolic disorders, hormonal disorders and a decrease in the body's resistance. Favorable conditions are created for the development of opportunistic microflora in the reproductive organs of cows, causing inflammatory processes that can lead to infertility, decreased milk productivity and large economic losses. All this justifies the great interest shown in the study of obstetric and gynecological pathology by veterinary specialists, who consider the development and implementation of preventive and therapeutic measures to combat infertility as an urgent and serious task. Postpartum endometritis is a common disease in dairy herds. Antibiotics in treatment regimens become ineffective because pathogens infecting the uterine cavity develop resistance to them. Complex remedies are needed that have antiseptic, myotropic, wound healing and anti-inflammatory effects. A therapeutic veterinary drug «Endoseptam» has been developed, its high effectiveness in the prevention and treatment of endometritis has been proven. Studies are being conducted to establish the safety profile of the product. This article presents the results of studying the embryotoxic effect of the newly developed drug. White rats were used in the experiment. The drug was administered to laboratory animals per os at doses of 2000 mg/ kg and 20,000 mg / kg during 19 days of pregnancy. On the 20th day of pregnancy, some of the animals were euthanized and autopsied to assess the effects of «Endoseptam» on developing embryos/fetuses. The remaining part of the animals in the experiment was monitored to record the growth and development of offspring. The data obtained confirm the absence of toxic effects on developing embryos/fetuses of a complex remedy for the prevention and treatment of endometritis. When observing the physical development of offspring, there were no violations of embryonic development manifested in the postnatal period of life. The drug «Endoseptam» does not have an embryotoxic effect.

Publisher

Saint-Petersburg State University of Veterinary Medicine

Reference12 articles.

1. Search and development of a treatment method for postpartum endometritis in cows / S. P. Pereryadkina, A. A. Boldarev, P. V. Kolesnikov, V. A. Galchenko // International Bulletin of Veterinary Medicine. – 2020. – № 2. – P. 204-209. (In Russ.)

2. Induced endometritis in early lactation compromises production and reproduction in dairy cows / A. Husnain, U. Arshad, M.B. Poindexter [et al.] // Journal of Dairy Science. – 2023. – Vol. 106, Iss. 6. – P. 4198–4213 – DOI 10.3168/jds.2022-22846. (In Eng.)

3. Uterine microbial ecology and disease in cattle: A review / U. Çömlekcioğlu, S. Jezierska, G. Opsomer, O. B. Pascottini // Theriogenology. – 2024. – Vol. 213. – P. 66–78. – DOI 10.1016/j.theriogenology.2023.09.016. (In Eng.)

4. Fungi of the genus Aspergillus – pathogens of animal and bird diseases / R. M. Potekhina, E. Y. Tarasova, L. E. Matrosova, et al. – Kazan: Federal Center for Toxicological, Radiation and Biological Safety, 2020. – 121 p. (In Russ.)

5. Microbiocenosis of the genital tract in cows with acute postpartum endometritis / R. R. Khamidullin, A.M. Tremasova, I. I. Idiyatov [et al.] // Veterinary doctor. – 2023. – № 1. – P. 64-69. – DOI 10.33632/1998-698X_2023_1_64. (In Russ.)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3